News
Life Sciences M&A Values Soar in 2011 May 14, 2012 | Press Release
Life Sciences M&A Activity Heats Up in April, says Burrill & Company May 01, 2012 | Press Release
Burrill & Company Leads $12.9 Million Series E Round In WhiteGlove Health April 16, 2012 | Press Release
See all News
Holly Apgar
DirectorMs. Apgar has more than ten years of international business development experience. Prior to joining Burrill & Company, Ms. Apgar was the Director of Business Development for Sumitomo Corporation in their Life Science Division, where her business development activities focused on identifying new market opportunities and creating strategic partnerships with high-risk venture companies. While at Sumitomo she also served on the Biotech Steering Committee where she was responsible for making early stage investments and monitoring cash flow and management activities. Ms. Apgar received a B.A. in International Service from The American University in 1993 and an MBA in finance from the Kellogg School of Management.


